Improvement in Survival Outcomes of Acute Lymphoblastic Leukemia Patients Treated With Berlin-Frankfurt-Munster 76/79 Protocol
Introduction: Acute lymphoblastic leukemia (ALL) is a malignancy of the white blood cells and lymphoid lines of hematopoietic cells in the blood and bone marrow while lymphomas mostly involve the lymph nodes. This study showed the response rate of ALL treated with BFM (Berlin-Frankfurt-Munster) 76/7...
Main Authors: | Khansa Saleem, Muhammad Ilyas, Saad Razzaq, Fahad Maqbool, Qaiser Abbas, Aneem Abdullah, Abu Bakar Shahid |
---|---|
Format: | Article |
Language: | English |
Published: |
Shaikh Zayed Medical Complex, Lahore
2021-01-01
|
Series: | Proceedings |
Subjects: | |
Online Access: | https://proceedings-szmc.org.pk/index.php/szmc/article/view/70 |
Similar Items
-
Long-term results of Berlin-Frankfurt-Muenster based therapy for childhood and adolescents’ lymphoblastic lymphoma
by: S. S. Kulikova, et al.
Published: (2022-11-01) -
Toxicity assessment of acute lymphoblastic leukemia treatment protocol ALL IC-BFM 2002
by: T. T. Valiev, et al.
Published: (2022-07-01) -
Native and pegylated forms of L-asparaginase: the assessment of effectiveness and toxicity in acute lymphoblastic leukemia treated with Berlin–Frankfurt–Munster (BFM) protocol
by: M. A. Shervashidze, et al.
Published: (2024-12-01) -
Incidence of secondary malignancies in Polish children treated for acute lymphoblastic leukemia according to the ALL-IC BFM 2002 protocol
by: Kamila Wypyszczak, et al.
Published: (2024-12-01) -
Translocation ETS leukemia-acute myeloid leukemia 1 (TEL-AML1) gene fusion in childhood acute lymphoblastic leukemia
by: Sri Mulatsih, et al.
Published: (2009-10-01)